Oura's IPO Sends $6.2 Million to the Company, Not $2.2 Billion

Oura Inc. is offering 50 million shares in its Nasdaq listing at $40 to $44 each, according to the amended S-1 registration statement the company filed Monday with the Securities and Exchange Commission. Only 13.5 million of those shares, 27 percent of the offering, are newly issued by the company. The remaining 36.5 million come from existing shareholders selling into the listing.

The filing states the company "will receive net proceeds from this offering of approximately $532.6 million, based on an assumed initial public offering price of $42.00 per share," the midpoint of its range. But the same filing says Oura "will use approximately $526.4 million of the net proceeds from this offering to satisfy our anticipated tax withholding and remittance obligations related to the RSU Net Settlement," the cash owed on restricted stock units that convert and vest at listing. That leaves roughly $6.2 million of the deal's own primary proceeds for what the filing calls general corporate purposes, out of a transaction sized at up to $2.2 billion.

Who is actually selling

Forerunner Ventures, which first invested in Oura's $28 million Series B round in 2020, is the largest seller among existing shareholders, according to TechCrunch's read of the filing. The firm is offering roughly 28.7 million shares, about 9.3 percent of the company and close to 80 percent of all shares being sold by existing holders, for an expected payout near $1.2 billion at the midpoint price, more than 40 times the size of the entire $28 million round Forerunner entered in 2020, though the filing does not break out how much of that original round Forerunner itself put in, or what Forerunner added or sold in the rounds between.

That structure is the announced-versus-closed distinction that matters here: the $2.2 billion headline is the size of the transaction, not new capital raised by Oura. Roughly $1.53 billion of it, at the midpoint price, moves directly from new public investors to Forerunner and other existing holders, not into Oura's bank account.

The company that doesn't need the cash

The thin primary allocation lines up with a company that is no longer burning money. Oura reported $1.21 billion in revenue for the nine months ended June 30, up 74 percent from $697.6 million a year earlier, and net income of $60.8 million over that period, against $1.6 million a year earlier. Full fiscal 2025 revenue was $907.9 million, up 123 percent from fiscal 2024's $406.8 million. Paid membership subscriptions, the higher-margin business at an 89 percent gross margin, brought in $240.5 million of that total, while hardware sales brought in $974 million.

Executive pay ahead of the listing is modest next to those figures: chief executive Thomas Hale's total fiscal 2025 compensation was $1 million, including a $600,000 salary set at the start of the year and a $495,000 cash bonus, according to compensation figures in the filing reported by Medical Design & Outsourcing. Chief Financial Officer Sean Brecker's total compensation was $655,528, and Chief Operating Officer Michael Chapp's was $673,920. Oura's headcount reached 1,350 across 11 countries as of June, while research and development spending for the nine months more than doubled year over year to $206.8 million.

How the valuation got here

Oura's private valuation moved from $5.2 billion in December 2024, when it raised $200 million, to $11 billion in October 2025, when it raised $900 million, according to TechCrunch's reporting on the company's funding history. The IPO's midpoint price implies a fully diluted valuation of about $13 billion, and the top of the range implies roughly $14.1 billion, both below the $15.62 billion figure the company has floated as a target. Paid membership climbed from 2.5 million members a year earlier to 5.0 million as of June 30, and the company sold 3.1 million rings over the nine-month period, which it estimates is about 2 percent of a 212-million-unit global wearables market. Goldman Sachs, Morgan Stanley and J.P. Morgan lead a syndicate of 18 underwriters on the deal, a large group for a company whose own take is a fraction of the headline size.

What would change this read

A company generating $60.8 million in nine-month net income does not need a primary raise to survive, which is the more charitable version of the same fact: Oura structured this listing to give employees and early backers liquidity rather than to fund the business, because the business is already funding itself. If the deal prices above its $40-to-$44 range or is upsized, Oura's own primary allocation would grow rather than the sellers' share, and unsubscribed demand for the smaller company tranche would be the first sign of that. The filing does not yet state a trading date; the underwriter section lists it as pending.

Oura's revenue, by period

1. FY2024406.8 $ millions
2. FY2025907.9 $ millions
3. 9mo through June 20261210 $ millions

Source: Oura S-1 filing with the SEC, accessed 2026-09-22

Offering party	Shares offered	Approx. value at $42 midpoint
Oura (company)	13.5 million	$567 million
Existing shareholders	36.5 million	$1.53 billion

Oura's structure is a sharper version of what Profound's Series D and Savvy Wealth's Series C showed at the private-round stage this month: how a headline number is split between the company and its earlier backers is the more useful question than the headline itself.